Abstract
One of the most delicate tasks of the medical profession is caring for the terminal cancer patient suffering from intolerable pain with no prospect of recovery. However desperate the situation is, the physician is always bound by the Hippocratic oath to alleviate pain by all efforts, even when the inevitable end is approaching. A recently (re)discovered reaction of primary sensory neurons, transganglionic degenerative atrophy (see Discussion), offers a new, noninvasive technique of alleviating pain in terminal cancer patients by means of iontophoretic application of microtubule inhibitors to the skin. The result of this treatment in seven cancer patients is described and the possible mechanisms underlying these therapy results are discussed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
